[1] Atwal GS, Bond GL, Metsuyanim S, Papa M, Friedman E, Distelman-Menachem T, Ben Asher E, Lancet D, Ross DA, Sninsky J, White TJ, Levine AJ, Yarden R. Haplotype structure and selection of the MDM2 oncogene in humans. Proc Natl Acad Sci USA, 2007, 104(11): 4524-4529.[2] Murphy ME. Polymorphic variants in the p53 pathway. Cell Death Differ, 2006, 13(6): 916-920.[3] Kay C, Jeyendran RS, Coulam CB. p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. Reprod Biomed Online, 2006, 13(4): 492-496.[4] Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature, 2007, 450(7170): 721-724.[5] Lin J, Wu X, Chen J, Chang A, Levine AJ. Functions of the p53 protein in growth regulation and tumor suppression. Cold Spring Harb Symp Quant Biol, 1994, 59: 215-223.[6] Takahama Y, Ochiya T, Sasaki H, Baba-Toriyama H, Konishi H, Nakano H, Terada M. Molecular cloning and functional analysis of cDNA encoding a rat leukemia in-hibitory factor: towards generation of pluripotent rat em-bryonic stem cells. Oncogene, 1998, 16(24): 3189-3196.[7] Menendez D, Inga A, Resnick MA. The expanding universe of p53 targets. Nat Rev Cancer, 2009, 9(10): 724-737.[8] Feng Z, Zhang C, Kang HJ, Sun Y, Wang H, Naqvi A, Frank AK, Rosenwaks Z, Murphy ME, Levine AJ, Hu W. Regulation of female reproduction by p53 and its family members. FASEB J, 2011, 25(7): 2245-2255.[9] Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature, 1992, 359(6390): 76-79.[10] Cheng TC, Huang CC, Chen CI, Liu CH, Hsieh YS, Huang CY, Lee MS, Liu JY. Leukemia inhibitory factor antisense oligonucleotide inhibits the development of murine embryos at preimplantation stages. Biol Reprod, 2004, 70(5): 1270-1276.[11] Fry RC. The effect of leukaemia inhibitory factor (LIF) on embryogenesis. Reprod Fertil Dev, 1992, 4(4): 449-458.[12] Cheng JG, Rodriguez CI, Stewart CL. Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: towards a molecular understanding of "the window of im-plantation". Rev Endocr Metab Disord, 2002, 3(2): 119- 126.[13] Vogiagis D, Salamonsen LA, Sandeman RM, Squires TJ, Butt AR, Fry RC. Effect of immunisation against leukae-mia inhibitory factor on the establishment of pregnancy in sheep. Reprod Nutr Dev, 1997, 37(4): 459-468.[14] Gearing DP, Thut CJ, VandeBos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J, 1991, 10(10): 2839-2848.[15] Nakamura H, Kimura T, Ogita K, Nakamura T, Takemura M, Shimoya K, Koyama S, Tsujie T, Koyama M, Murata Y. NF-kappaB activation at implantation window of the mouse uterus. Am J Reprod Immunol, 2004, 51(1): 16-21.[16] Bischof P, Haenggeli L, Campana A. Effect of leukemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway. Am J Reprod Immunol, 1995, 34(4): 225-230.[17] Bamberger AM, Jenatschke S, Schulte HM, LoningT, Bamberger MC. Leukemia inhibitory factor (LIF) stimu-lates the human HLA-G promoter in JEG3 choriocarci-noma cells. J Clin Endocrinol Metab, 2000, 85(10): 3932-3936.[18] Hirota Y, Daikoku T, Tranguch S, Xie H, Bradshaw HB, Dey SK. Uterine-specific p53 deficiency confers prema-ture uterine senescence and promotes preterm birth in mice. J Clin Invest, 2010, 120(3): 803-815.[19] Feng Z, Zhang C, Kang HJ, Sun Y, Wang H, Naqvi A, Frank AK, Rosenwaks Z, Murphy ME, Levine AJ, Hu W. Regulation |